Access to innovation through the French Expanded-Access Program and clinical trials in patients with malignant melanoma.

被引：0
|
作者：
Christen, Claire
Belgodere, Laetitia
Guillot, Bernard
Kerouani-Lafaye, Ghania
Brunel, Liora
Turcry, Florence
Monard, Adrien
Grude, Francoise
Guyader, Gaelle
Boudali, Lotfi
Albin, Nicolas
机构：
[1] French Natl Agcy Med & Hlth Prod Safety ANSM, St Denis, France
[2] CHU Montpellier, Univ Hosp Montpellier, Dermatol Dept, Montpellier, France
[3] Grp Hosp Mutualiste Grenoble, Grenoble, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22030
引用
收藏
页数：2
相关论文
共 50 条
  • [41] An expanded-access clinical study of thiotepa (DSP-1958) high-dose chemotherapy before autologous hematopoietic stem cell transplantation in patients with malignant lymphoma
    Momoko Nishikori
    Yasufumi Masaki
    Nobuharu Fujii
    Takashi Ikeda
    Mariko Takahara-Matsubara
    Saori Sugimoto
    Eisei Kondo
    International Journal of Hematology, 2022, 115 : 391 - 398
  • [42] Geographic disparities in access to immunotherapy clinical trials for metastatic melanoma
    Mulligan, Kathleen M.
    Zheng, David X.
    Xu, James R.
    Cullison, Christopher R.
    Cwalina, Thomas B.
    Beveridge, Mara G.
    Scott, Jeffrey F.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (04) : 1033 - 1036
  • [43] Geographic disparities in access to immunotherapy clinical trials for metastatic melanoma
    Kathleen M. Mulligan
    David X. Zheng
    James R. Xu
    Christopher R. Cullison
    Thomas B. Cwalina
    Mara G. Beveridge
    Jeffrey F. Scott
    Archives of Dermatological Research, 2023, 315 : 1033 - 1036
  • [44] Pemetrexed in the treatment of malignant mesothelioma: Results from an expanded access program in Germany
    Reck, Martin
    Stahel, Rolf A.
    von Pawel, Joachim
    Karthaus, Meinolf
    Korfee, Soenke
    Serke, Monika
    Schuette, Wolfgang H. -W.
    Eschbach, Corinna
    Fink, Thomas H.
    Leschinger, Monika I.
    Manegold, Christian
    RESPIRATORY MEDICINE, 2010, 104 (01) : 142 - 148
  • [45] Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program
    Gans, Hayley
    Chemaly, Roy F.
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [46] Pemetrexed with or without a platinum compound in patients with malignant mesothelioma: A single institution "Expanded Access Program" experience
    Baas, P
    Burgers, S
    Lieverst, J
    Dalesio, O
    van Zandwijk, N
    LUNG CANCER, 2005, 49 : S219 - S219
  • [47] A call to action: Patients' access to clinical trials
    Sadler, GR
    HEALTH & SOCIAL WORK, 2001, 26 (03) : 196 - 200
  • [48] Desmoplastic malignant melanoma. Clinical and histopathological results from 34 patients
    Rutten, A
    Hugel, H
    Kutzner, H
    Schirren, CG
    Kuchler, A
    Groth, W
    HAUTARZT, 1996, 47 (06): : 447 - 453
  • [49] A call to action: Patients' access to clinical trials
    Sadler, GR
    HEALTH & SOCIAL WORK, 2003, 28 (01) : 79 - 80
  • [50] Impact of simultaneous radiotherapy in melanoma patients treated with pembrolizumab in the French early access program.
    Saiag, Philippe
    Mortier, Laurent
    Dutriaux, Caroline
    Benmahammed, Lynda
    Morsli, Ouzna
    Tadmouri, Abir
    Hunault, Catherine
    Leccia, Marie Therese
    Meyer, Nicolas
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345